Four Western states are taking a different approach from the CDC on vaccines for COVID-19, influenza, and RSV.

Eric K. Singhi, MD, is a thoracic oncologist at MD Anderson Cancer Center in Houston and one of Cancer Therapy Advisor’s editorial board members. He shares his top 5 presentations from the 2025 World ...

Illinois health officials are warning residents to be on alert after the state’s first case of Powassan virus was confirmed in a resident who became seriously ill.

The prevalence of ever, current, and daily use of nicotine pouches was low; a significantly higher prevalence was seen for adults who were male and non-Hispanic White. HealthDay News — The percentage ...

An abnormal spirometry phenotype has been found by age 8 in more than 25% of children born extremely preterm or extremely low birth weight.

Long COVID remains globally prevalent following COVID-19 infection, with a significant burden of symptoms lasting 1 to 2 years postinfection.

Nocturnal gastro-esophageal reflux (nGER) has no significant link to pulmonary abnormalities in middle-aged adults.

A phase 3 trial evaluating benralizumab for the treatment of COPD did not meet its primary endpoint, according to AstraZeneca.

The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over 2 seasons.

Chronic exposure to PM2.5 is associated with increased risk of developing AD, with variation across demographic characteristics.

Topline data were announced from a phase 3 trial evaluating dexpramipexole as an add-on therapy in patients with eosinophilic asthma.

The FDA has approved updated prescribing information for Airsupra to include the BATURA study in patients with mild asthma.